Skip to main content
OpenTrials

Clinical trial condition

Colo-rectal Cancer

Explore clinical trials studying Colo-rectal Cancer. Study availability and eligibility vary by location and protocol.

121 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Colo-rectal Cancer trial results

Recruiting

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

NCT07058012

Conditions
Colo-rectal Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa - Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • Missouri Baptist St Louis, Missouri, United States
View Trial Details
Recruiting

The AIDPRO-CRC Trial

NCT06645015

Conditions
Colo-rectal Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
Locations
  • Aalborg University Hospital, Department of Gastrointestinal Surgery Aalborg, Denmark
  • Regional Hospital Gødstrup, Department of Surgery Herning, Denmark
  • Copenhagen University Hospital - North Zealand, Hillerød, Department of Surgery Hillerød, Denmark
  • Copenhagen University Hospital Hvidovre, Gastro Unit, Surgical Division Hvidovre, Denmark
View Trial Details
Recruiting

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

NCT07450612

Conditions
Adenoma Colon, Adenoma Colon Polyp, Colo-rectal Cancer, +37 more
Locations
  • Gastronterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Hospital Milan, Lombardy, Italy
  • Prof Giulia Martina Cavestro, MD PhD Milan, Lombardy, Italy
  • San Raffaele Scientific Institute, Gastroenterology and Gastrointestinal Endoscopy Unit Milan, Lombardy, Italy
  • Dipartimento di Chirurgia Oncologica e Dipartimento di Oncologia Sperimentale Istituto Nazionale Tumori Milan, MI, Italy
View Trial Details
Recruiting

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

NCT07145255

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • START, Midwest Grand Rapids, Michigan, United States
  • START, Astera East Brunswick, New Jersey, United States
  • NEXT, Dallas Irving, Texas, United States
View Trial Details

Related conditions